A study of a liquid gel for brain AVM treatment
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a liquid embolic agent (a gel-like material) injected into the blood vessels of a brain arteriovenous malformation (AVM) to block abnormal blood flow. It’s for people aged 18 to 80 with certain types of AVMs that doctors think can be treated this way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a brain AVM that was found using a CT, MRI, or angiogram (a special X-ray of blood vessels).
- Your AVM is classified as Spetzler-Martin grade I to IV (a standard way to rate AVM complexity).
- You and/or your guardian understand the study and agree to take part.
- Your doctor believes your AVM can be treated with this liquid gel material.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical and imaging information from people with a brain arteriovenous malformation (AVM) to understand how different treatments are used in real life. It may help doctors improve future care, even if you are not receiving a new drug in this study.
This trial tests a new liquid material (called a liquid embolic system) that is injected into the abnormal blood vessels in the brain to block them off. It is for people who have a cerebrovascular malformation and can be treated with a catheter from inside the blood vessel.
This trial uses a blood test to look for genetic mutations in brain arteriovenous malformations (bAVMs). It may help doctors understand these lesions better and guide treatment.
This trial tests an oral medication called FCN-159 for people with a high-grade brain AVM that has never bled. The goal is to see if it can shrink the AVM or prevent future problems.
This study tests a new coil device used during a procedure to block abnormal blood vessels in the brain or other areas. It aims to see how safe and effective the coil is for treating arteriovenous malformations.
This trial tests whether a minimally invasive procedure to block a specific type of abnormal connection between brain blood vessels can help preserve or improve memory and thinking. It is being studied in people who have not yet had bleeding from this condition.
Hear when a new Arteriovenous Fistula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.